Affimed Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for Âą?ÂąTb-KLK3-mAb Phase I Clinical Trial in Australia